5, 17 This strongly implicated PHB downregulation or inactivation as a mechanism for the sensitisation of prostate cancer cells to low androgen levels/low potency ligands during apparent androgen ablation.14 This evidence concerns the gene PHB1 and Familial prostate cancer.